Relationship between serum anion gap and mortality in ICU in multiple myeloma patients in the MIMIC database: A retrospective cohort study.

<h4>Background</h4>Serum anion gap has diagnostic value in patients with multiple myeloma, but its association with ICU mortality and threshold value remain unclear.<h4>Methods</h4>Multiple myeloma patients meeting criteria were selected from the Medical Information Mart for...

Full description

Saved in:
Bibliographic Details
Main Authors: Qianhui Wang, Pengyu Hu, Haibo Cong
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0328014
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:<h4>Background</h4>Serum anion gap has diagnostic value in patients with multiple myeloma, but its association with ICU mortality and threshold value remain unclear.<h4>Methods</h4>Multiple myeloma patients meeting criteria were selected from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. The exposure factor was serum anion gap, and the outcome was ICU in-hospital mortality. Multivariable-adjusted Cox regression, curve fitting, and forest plots were used to evaluate the relationship between anion gap and ICU mortality in multiple myeloma patients.<h4>Results</h4>A total of 323 eligible subjects were included (206 males [63.8%], 117 females [36.2%]). Multivariable Cox regression showed that each 1-unit increase in AG was associated with a 7% increased mortality risk (HR = 1.07, 95%CI = 1.01-1.14, P = 0.032). Curve fitting revealed a nonlinear relationship between anion gap and ICU mortality (nonlinear P = 0.038), with the lowest risk at 15.29 mmol/L. Incorporating AG into traditional risk factor models improved mortality prediction (P = 0.038).<h4>Conclusion</h4>Serum anion gap exhibits a nonlinear relationship with ICU mortality in multiple myeloma patients, with the lowest risk observed at approximately 15.29 mmol/L.
ISSN:1932-6203